DRICH1/C22orf43 Antikörper (AA 1-100) (Biotin)

Produktnummer ABIN1699901

Produktdetails anti-DRICH1/C22orf43 Antikörper (Biotin)

Target: DRICH1/C22orf43 (C22orf43) (Chromosome 22 Open Reading Frame 43 (C22orf43))

Bindungsspezifität: AA 1-100

Reaktivität: Human, Ratte

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser DRICH1/C22orf43 Antikörper ist konjugiert mit Biotin

Applikation: Western Blotting (WB), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), ELISA

Kreuzreaktivität: Human, Ratte

Aufreinigung: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human C22orf43

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C for 12 months.

Haltbarkeit: 12 months

Details zu DRICH1/C22orf43

Target: DRICH1/C22orf43 (C22orf43) (Chromosome 22 Open Reading Frame 43 (C22orf43))

Andere Bezeichnung: C22orf43 (C22orf43 Produkte)

Synonyme: aspartate rich 1 antikoerper, DRICH1 antikoerper

Hintergrund:

Synonyms: C22orf43, Chromosome 22 open reading frame 43, CV043_HUMAN, Putative uncharacterized protein C22orf43, Uncharacterized protein C22orf43.

Background: C22orf43 (chromosome 22 open reading frame 43), also known as MGC33025 or MGC75009, is a 229 amino acid protein encoded by a gene located on human chromosome 22, which contains over 500 genes and about 49 million bases. As the second smallest human chromosome, chomosome 22 contains a wide variety of genes with numerous functions. Phelan-McDermid syndrome, Neurofibromatosis type 2 and autism are associated with chromosome 22. A schizophrenia susceptibility locus has been identified on chromosome 22 and studies show that 22q11 deletion symptoms include a high incidence of schizophrenia. Translocations between chromosomes 9 and 22 may lead to the formation of the Philadelphia Chromosome and the subsequent production of the novel fusion protein, BCR-Abl, a potent cell proliferation activator found in several types of leukemia.

Gen-ID: 51233